617 related articles for article (PubMed ID: 28696089)
1. Prevention of sudden cardiac death: from wearable to subcutaneous cardioverter defibrillator.
Viani S; Soldati E; DI Cori A; Segreti L; Paperini L; DE Lucia R; Zucchelli G; Bongiorni MG
Minerva Cardioangiol; 2018 Feb; 66(1):83-99. PubMed ID: 28696089
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous implantable cardioverter defibrillator indication in prevention of sudden cardiac death in difficult clinical situations: A French expert position paper.
Probst V; Boveda S; Sadoul N; Marquié C; Chauvin M; Mondoly P; Gras D; Jacon P; Defaye P; Leclercq C; Anselme F
Arch Cardiovasc Dis; 2020 May; 113(5):359-366. PubMed ID: 32334981
[TBL] [Abstract][Full Text] [Related]
3. Current Device Therapies for Sudden Cardiac Death Prevention - the ICD, Subcutaneous ICD and Wearable ICD.
Chieng D; Paul V; Denman R
Heart Lung Circ; 2019 Jan; 28(1):65-75. PubMed ID: 30389367
[TBL] [Abstract][Full Text] [Related]
4. How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation?
Randles DA; Hawkins NM; Shaw M; Patwala AY; Pettit SJ; Wright DJ
Europace; 2014 Jul; 16(7):1015-21. PubMed ID: 24351884
[TBL] [Abstract][Full Text] [Related]
5. Long-term use of the wearable cardioverter defibrillator in patients with explanted ICD.
Kaspar G; Sanam K; Gholkar G; Bianco NR; Szymkiewicz S; Shah D
Int J Cardiol; 2018 Dec; 272():179-184. PubMed ID: 30121177
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of subcutaneous implantable cardioverter-defibrillators and determinants of inappropriate shock delivery.
Mesquita J; Cavaco D; Ferreira A; Lopes N; Santos PG; Carvalho MS; Haas A; Costa F; Carmo P; Morgado F; Adragão P; Mendes M
Int J Cardiol; 2017 Apr; 232():176-180. PubMed ID: 28082086
[TBL] [Abstract][Full Text] [Related]
7. Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indication.
Boersma LV; Barr CS; Burke MC; Leon AR; Theuns DA; Herre JM; Weiss R; Kremers MS; Neuzil P; Husby MP; Carter N; Stivland TM; Gold MR;
Heart Rhythm; 2017 Mar; 14(3):367-375. PubMed ID: 27890798
[TBL] [Abstract][Full Text] [Related]
8. Experts of the Heart Rhythm Section of the Polish Cardiac Society: opinion on the use of wearable cardioverter-defibrillators in Poland.
Sterliński M; Oręziak A; Przybylski A; Średniawa B
Kardiol Pol; 2019; 77(2):238-243. PubMed ID: 30816992
[TBL] [Abstract][Full Text] [Related]
9. Implant and clinical characteristics for pediatric and congenital heart patients in the national cardiovascular data registry implantable cardioverter defibrillator registry.
Jordan CP; Freedenberg V; Wang Y; Curtis JP; Gleva MJ; Berul CI
Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1092-100. PubMed ID: 25287482
[TBL] [Abstract][Full Text] [Related]
10. Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator.
Skowasch D; Ringquist S; Nickenig G; Andrié R
PLoS One; 2018; 13(3):e0194496. PubMed ID: 29566033
[TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of Subcutaneous Cardioverter Defibrillator in Patients at High Risk of Sudden Cardiac Death - Primary Japanese Experience.
Sasaki S; Tomita H; Tsurugi T; Ishida Y; Shoji Y; Nishizaki K; Kinjo T; Endo T; Nishizaki F; Hanada K; Sasaki K; Horiuchi D; Kimura M; Higuma T; Okamatsu H; Tanaka Y; Koyama J; Okumura K
Circ J; 2018 May; 82(6):1546-1551. PubMed ID: 29643282
[TBL] [Abstract][Full Text] [Related]
12. Deactivation of implantable cardioverter-defibrillators: results of patient surveys.
Herman D; Stros P; Curila K; Kebza V; Osmancik P
Europace; 2013 Jul; 15(7):963-9. PubMed ID: 23447573
[TBL] [Abstract][Full Text] [Related]
13. [Implantable cardioverter defibrillators in the prevention of sudden cardiac death].
Bockeria LA; Neminushchiy NM; Mikhaylichenko SI; Novichkov SA; Achkasov EE
Ter Arkh; 2017; 89(12):103-109. PubMed ID: 29411768
[TBL] [Abstract][Full Text] [Related]
14. Low Prevalence of Inappropriate Shocks in Patients With Inherited Arrhythmia Syndromes With the Subcutaneous Implantable Defibrillator Single Center Experience and Long-Term Follow-Up.
Rudic B; Tülümen E; Berlin V; Röger S; Stach K; Liebe V; El-Battrawy I; Dösch C; Papavassiliu T; Akin I; Borggrefe M; Kuschyk J
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042423
[TBL] [Abstract][Full Text] [Related]
15. [The wearable cardioverter defibrillator - temporary protection against sudden cardiac death].
Almqvist M; Mattsson G; Magnusson P
Lakartidningen; 2019 Apr; 116():. PubMed ID: 31192401
[TBL] [Abstract][Full Text] [Related]
16. The implantable cardioverter-defibrillator: An update.
Miller JD; Yousuf O; Berger RD
Trends Cardiovasc Med; 2015 Oct; 25(7):606-11. PubMed ID: 25912255
[TBL] [Abstract][Full Text] [Related]
17. Recommendations for driving after implantable cardioverter defibrillator implantation and the use of a wearable cardioverter defibrillator : Different viewpoints around the world.
Cooper M; Berent T; Auer J; Berent R
Wien Klin Wochenschr; 2020 Dec; 132(23-24):770-781. PubMed ID: 32435868
[TBL] [Abstract][Full Text] [Related]
18. Prevention of Sudden Cardiac Death: Focus on the Subcutaneous Implantable Cardioverter-Defibrillator.
Adduci C; Palano F; Silvetti G; Cosentino P; Francia P
High Blood Press Cardiovasc Prev; 2020 Aug; 27(4):291-297. PubMed ID: 32519207
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous implantable cardiac defibrillators: indications and limitations.
Bongiorni MG; Viani S; Zucchelli G; Di Cori A; Segreti L; Paperini L; Levorato D; Boem A; Branchitta G; Andreini D; Soldati E
Curr Heart Fail Rep; 2015 Feb; 12(1):79-86. PubMed ID: 25475178
[TBL] [Abstract][Full Text] [Related]
20. Use of the Wearable Cardioverter Defibrillator as a Bridge to Implantable Cardioverter Defibrillator.
Weinstock J
Card Electrophysiol Clin; 2018 Mar; 10(1):11-16. PubMed ID: 29428131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
